SE8800613D0
(sv)
|
1988-02-23 |
1988-02-23 |
Wallac Oy |
A novel spectrofluorometric method and compounds that are of value for the method
|
JPH03287584A
(ja)
|
1990-04-05 |
1991-12-18 |
Banyu Pharmaceut Co Ltd |
置換アリルアミン誘導体
|
US5250534A
(en)
|
1990-06-20 |
1993-10-05 |
Pfizer Inc. |
Pyrazolopyrimidinone antianginal agents
|
US6200980B1
(en)
|
1995-06-07 |
2001-03-13 |
Cell Pathways, Inc. |
Method of treating a patient having precancerous lesions with phenyl purinone derivatives
|
IL132276A0
(en)
|
1997-04-25 |
2001-03-19 |
Pfizer |
Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cgmp pde5) for the treatment of sexual dysfunction
|
KR100449790B1
(ko)
|
1998-04-20 |
2004-09-22 |
화이자 인코포레이티드 |
성기능장애를 치료하기 위한, 유형 5의 환상 구아노신3',5'-모노포스페이트 포스포디에스테라제에 대한피라졸로피리미디논 저해제
|
JP2000038350A
(ja)
|
1998-05-18 |
2000-02-08 |
Yoshitomi Pharmaceut Ind Ltd |
糖尿病治療薬
|
GB9823101D0
(en)
|
1998-10-23 |
1998-12-16 |
Pfizer Ltd |
Pharmaceutically active compounds
|
GB9823102D0
(en)
|
1998-10-23 |
1998-12-16 |
Pfizer Ltd |
Pharmaceutically active compounds
|
CZ27399A3
(cs)
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
IN187433B
(es)
|
1999-09-10 |
2002-04-27 |
Cipla Ltd |
|
WO2001019827A1
(en)
|
1999-09-13 |
2001-03-22 |
Cipla Ltd. |
A novel process for the synthesis of sildenafil citrate
|
CA2385769A1
(en)
|
1999-09-17 |
2001-03-22 |
Gavin C. Hirst |
Kinase inhibitors as therapeutic agents
|
DE60018769T2
(de)
|
1999-09-24 |
2005-08-04 |
Nihon Nohyaku Co., Ltd. |
Aromatische diamid-derivate oder ihre salze, chemikalien für die landwirtschaft/den gartenbau und verfahren zu ihrer anwendung
|
NZ517324A
(en)
|
1999-10-11 |
2003-09-26 |
Pfizer |
5-(2-substituted-5-heterocyclylsulphonylpyrid-3-YL)- dihydropyrazolo[4,3-d]pyrimidin-7-ones as phosphodiesterase inhibitors
|
TWI265925B
(en)
|
1999-10-11 |
2006-11-11 |
Pfizer |
Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
|
IL139073A0
(en)
|
1999-10-21 |
2001-11-25 |
Pfizer |
Treatment of neuropathy
|
HUP0204412A3
(en)
|
1999-12-22 |
2003-05-28 |
Nihon Nohyaku Co Ltd |
Insecticidal aromatic diamide derivatives, compositions containing them and use thereof
|
CO5271697A1
(es)
|
2000-01-12 |
2003-04-30 |
Pfizer Prod Inc |
Composiciones y procedimientos para el tratamiento de afecciones que responden a un aumento de testosterona
|
US20020013327A1
(en)
|
2000-04-18 |
2002-01-31 |
Lee Andrew G. |
Compositions and methods for treating female sexual dysfunction
|
AU1560802A
(en)
|
2000-06-28 |
2002-01-08 |
Smithkline Beecham Plc |
Wet milling process
|
WO2002016348A1
(en)
|
2000-08-09 |
2002-02-28 |
Astrazeneca Ab |
Antiangiogenic bicyclic derivatives
|
WO2002019975A1
(fr)
|
2000-09-05 |
2002-03-14 |
Taisho Pharmaceutical Co., Ltd. |
Stimulants de la croissance des cheveux
|
US6548508B2
(en)
|
2000-10-20 |
2003-04-15 |
Pfizer, Inc. |
Use of PDE V inhibitors for improved fecundity in mammals
|
WO2002049651A1
(de)
|
2000-12-19 |
2002-06-27 |
Merck Patent Gmbh |
Pharmazeutische formulierung enthaltend pyrazolo[4,3-d]pyrimidine und antithrombotica, calcium-antagonisten, prostaglandine oder prostaglandinderivate
|
WO2002050073A1
(en)
|
2000-12-19 |
2002-06-27 |
Smithkline Beecham P.L.C. |
Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors
|
US6402829B1
(en)
*
|
2000-12-20 |
2002-06-11 |
Sun Chemical Corporation |
Process for preparing a substantially pure gamma phase quinacridone pigment of large particle size
|
US6770645B2
(en)
|
2001-03-16 |
2004-08-03 |
Pfizer Inc. |
Pharmaceutically active compounds
|
US6784185B2
(en)
|
2001-03-16 |
2004-08-31 |
Pfizer Inc. |
Pharmaceutically active compounds
|
JP4196678B2
(ja)
|
2001-04-26 |
2008-12-17 |
味の素株式会社 |
複素環化合物
|
EP1383760A1
(en)
|
2001-04-30 |
2004-01-28 |
Fujisawa Pharmaceutical Co., Ltd. |
Biarylcarboxamide compounds as apolipoprotein b inhibitors
|
FR2825706B1
(fr)
|
2001-06-06 |
2003-12-12 |
Pf Medicament |
Nouveaux derives de benzothienyle ou d'indole, leur preparation et leur utilisation comme inhibiteurs de proteines prenyl transferase
|
KR20040053210A
(ko)
|
2001-11-02 |
2004-06-23 |
화이자 프로덕츠 인크. |
Pde9 억제제를 사용한 인슐린 저항 증후군 및 2형당뇨병의 치료
|
TW200738672A
(en)
|
2001-12-10 |
2007-10-16 |
Bristol Myers Squibb Co |
Intermediated for the preparation of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
|
US7166293B2
(en)
|
2002-03-29 |
2007-01-23 |
Carlsbad Technology, Inc. |
Angiogenesis inhibitors
|
US20050119278A1
(en)
|
2002-05-16 |
2005-06-02 |
Che-Ming Teng |
Anti-angiogenesis methods
|
IL164209A0
(en)
|
2002-05-31 |
2005-12-18 |
Eisai Co Ltd |
Pyrazole derivatives and pharmaceutical compositions containing the same
|
BRPI0407493A
(pt)
|
2003-02-14 |
2006-02-14 |
Wyeth Corp |
derivados heterociclil-3-sulfinilazaindol ou -azaindazol como ligantes de 5-hidroxitriptamina-6
|
DE602004024375D1
(de)
|
2003-02-14 |
2010-01-14 |
Glaxo Group Ltd |
Carboxamidderivate
|
WO2004087906A1
(en)
|
2003-03-31 |
2004-10-14 |
Pfizer Products Inc. |
Crystal structure of 3',5'-cyclic nucleotide phosphodiesterase 1b (pde1b) and uses thereof
|
RS20050810A
(en)
|
2003-04-29 |
2007-08-03 |
Pfizer Inc., |
5,7-diaminopyrazolo(4,3-d)pyrimidines useful in the treatment of hypertension
|
US20050004133A1
(en)
|
2003-06-05 |
2005-01-06 |
Makings Lewis R. |
Modulators of VR1 receptor
|
JP2007505950A
(ja)
|
2003-06-10 |
2007-03-15 |
フルクラム・ファーマシューティカルズ・インコーポレーテッド |
β−ラクタマーゼ阻害剤およびその使用方法
|
ZA200305330B
(en)
|
2003-07-10 |
2004-05-26 |
Jb Chemicals & Pharmaceuticals |
An improved process for the preparation of 5-[2-ethoxy-5-(4-methylpiperazin-1-ylsulphonyl)phenyl]-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazole[4,3-D]P yrimidin-7-one.
|
JP2007500700A
(ja)
|
2003-07-29 |
2007-01-18 |
スミスクライン ビーチャム コーポレーション |
化合物
|
TWI339206B
(en)
|
2003-09-04 |
2011-03-21 |
Vertex Pharma |
Compositions useful as inhibitors of protein kinases
|
AU2004293018B2
(en)
|
2003-11-19 |
2010-02-18 |
Array Biopharma Inc. |
Heterocyclic inhibitors of MEK and methods of use thereof
|
US7241773B2
(en)
|
2003-12-22 |
2007-07-10 |
Abbott Laboratories |
3-quinuclidinyl heteroatom bridged biaryl derivatives
|
US20050137398A1
(en)
|
2003-12-22 |
2005-06-23 |
Jianguo Ji |
3-Quinuclidinyl heteroatom bridged biaryl derivatives
|
GB0402137D0
(en)
|
2004-01-30 |
2004-03-03 |
Smithkline Beecham Corp |
Novel compounds
|
DE102004005172A1
(de)
|
2004-02-02 |
2005-08-18 |
Aventis Pharma Deutschland Gmbh |
Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
|
EP1720878A1
(en)
|
2004-02-27 |
2006-11-15 |
F.Hoffmann-La Roche Ag |
Heteroaryl-fused pyrazolo derivatives
|
BRPI0508036A
(pt)
|
2004-02-27 |
2007-07-17 |
Hoffmann La Roche |
derivados fundidos de pirazola
|
JP2007526324A
(ja)
|
2004-03-02 |
2007-09-13 |
スミスクライン・ビーチャム・コーポレイション |
Akt活性のある阻害剤
|
AR050188A1
(es)
|
2004-08-03 |
2006-10-04 |
Uriach Y Compania S A J |
Compuestos heterociclicos condensados utiles en terapia como inhibidores de quinasas p38 y composiciones farmaceuticas que los contienen
|
CN102964294A
(zh)
|
2004-09-02 |
2013-03-13 |
遗传技术研究公司 |
Hedgehog信号转导的吡啶基抑制剂
|
WO2006038001A1
(en)
|
2004-10-06 |
2006-04-13 |
Celltech R & D Limited |
Aminopyrimidine derivatives as jnk inhibitors
|
WO2006045010A2
(en)
|
2004-10-20 |
2006-04-27 |
Resverlogix Corp. |
Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
|
AR051596A1
(es)
|
2004-10-26 |
2007-01-24 |
Irm Llc |
Compuestos heterociclicos condensados nitrogenados como inhibidores de la actividad del receptor canabinoide 1; composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos para el tratamiento de trastornos alimentarios
|
US20060100251A1
(en)
|
2004-10-28 |
2006-05-11 |
The Institutes For Pharmaceutical Discovery, Llc |
Substituted phenylalkanoic acids
|
US7919487B2
(en)
|
2004-11-10 |
2011-04-05 |
Synta Pharmaceuticals Corporation |
Heteroaryl compounds
|
CA2586870A1
(en)
|
2004-11-10 |
2006-05-18 |
Synta Pharmaceuticals Corp. |
Il-12 modulatory compounds
|
CA2587192A1
(en)
|
2004-11-10 |
2006-05-18 |
Cgi Pharmaceuticals, Inc. |
Imidazo[1 , 2-a] pyrazin-8-ylamines useful as modulators of kinase activity
|
DE102004054666A1
(de)
|
2004-11-12 |
2006-05-18 |
Bayer Cropscience Gmbh |
Substituierte Pyrazol-3-carboxamide, Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren
|
CN100516049C
(zh)
|
2004-11-16 |
2009-07-22 |
永信药品工业股份有限公司 |
抗血管生成药n2-(取代的芳基甲基)-3-(取代的苯基)吲唑的合成
|
CA2593578C
(en)
|
2005-01-07 |
2013-11-05 |
Emory University |
Cxcr4 antagonists for the treatment of medical disorders
|
AU2006230364B2
(en)
|
2005-03-31 |
2012-09-13 |
Janssen Pharmaceutica N.V. |
Bicyclic pyrazole compounds as antibacterial agents
|
WO2006128172A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating b cell regulated autoimmune disorders
|
US20100216798A1
(en)
|
2005-07-29 |
2010-08-26 |
Astellas Pharma Inc |
Fused heterocycles as lck inhibitors
|
WO2007019345A1
(en)
|
2005-08-04 |
2007-02-15 |
Sirtris Pharmaceuticals, Inc. |
Imidazopyridine derivatives as sirtuin modulating agents
|
GB0516703D0
(en)
|
2005-08-15 |
2005-09-21 |
Syngenta Participations Ag |
Novel insecticides
|
JP2007055940A
(ja)
|
2005-08-24 |
2007-03-08 |
Astellas Pharma Inc |
ピラゾロピリミジン誘導体
|
BRPI0614884A2
(pt)
|
2005-08-25 |
2011-04-19 |
Hoffmann La Roche |
inibidores de p38 map cinase e métodos para uso dos mesmos
|
MX2008002588A
(es)
|
2005-08-25 |
2008-03-18 |
Hoffmann La Roche |
Inhibidores de p38-map-cinasa y los metodos para utilizarlos.
|
CA2620257A1
(en)
|
2005-08-25 |
2007-03-01 |
F. Hoffmann-La Roche Ag |
P38 map kinase inhibitors and methods for using the same
|
EP1922311A2
(en)
|
2005-09-09 |
2008-05-21 |
Brystol-Myers Squibb Company |
Acyclic ikur inhibitors
|
WO2007041511A2
(en)
|
2005-09-30 |
2007-04-12 |
New York University |
Hematopoietic progenitor kinase 1 for modulation of an immune response
|
US20080242685A1
(en)
|
2005-10-25 |
2008-10-02 |
Smithkline Beecham Corporation |
Chemical Compounds
|
US20090318492A1
(en)
|
2005-11-03 |
2009-12-24 |
Han-Ting Chang |
Indole compounds having c4-acidic substituents and use thereof as phospholipase-a2 inhibitors
|
CN101312720A
(zh)
|
2005-11-30 |
2008-11-26 |
安斯泰来制药有限公司 |
2-氨基苯甲酰胺衍生物
|
GB0525143D0
(en)
|
2005-12-09 |
2006-01-18 |
Novartis Ag |
Organic compounds
|
CA2635997A1
(en)
|
2006-01-11 |
2007-07-19 |
Astrazeneca Ab |
Morpholino pyrimidine derivatives and their use in therapy
|
TW200808766A
(en)
|
2006-02-16 |
2008-02-16 |
Syngenta Participations Ag |
Novel insecticides
|
EP2004626A4
(en)
|
2006-03-23 |
2010-10-27 |
Synta Pharmaceuticals Corp |
BENZIMIDAZOLYL-PYRIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND IMMUNE DISORDERS
|
ES2388881T3
(es)
|
2006-03-30 |
2012-10-19 |
Irm Llc |
Azolopirimidinas como inhibidores de la actividad cannabinoide 1
|
CN102516241B
(zh)
|
2006-05-19 |
2015-07-29 |
艾伯维巴哈马有限公司 |
Cns活性的稠合的双环杂环取代的氮杂双环烷烃衍生物
|
US20080280891A1
(en)
|
2006-06-27 |
2008-11-13 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
WO2008008059A1
(en)
|
2006-07-12 |
2008-01-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents ans uses thereof
|
PE20080403A1
(es)
|
2006-07-14 |
2008-04-25 |
Amgen Inc |
Derivados heterociclicos fusionados y metodos de uso
|
GB0614691D0
(en)
|
2006-07-24 |
2006-08-30 |
Syngenta Participations Ag |
Insecticidal compounds
|
KR20090063240A
(ko)
|
2006-10-06 |
2009-06-17 |
아이알엠 엘엘씨 |
단백질 키나제 억제제 및 그의 사용 방법
|
WO2008070313A2
(en)
|
2006-10-20 |
2008-06-12 |
Concert Pharmaceuticals Inc. |
3-(dihydro-1h-pyrazolo [4,3-d] pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
|
WO2008089310A2
(en)
|
2007-01-18 |
2008-07-24 |
Lexicon Pharmaceuticals, Inc. |
Delta 5 desaturase inhibitors for the treatment of obesity
|
WO2008089307A2
(en)
|
2007-01-18 |
2008-07-24 |
Lexicon Pharmaceuticals, Inc. |
Delta 5 desaturase inhibitors for the treatment of pain, inflammation and cancer
|
US20140249135A1
(en)
|
2007-03-01 |
2014-09-04 |
Novartis Ag |
Pim kinase inhibitors and methods of their use
|
EP2002835A1
(en)
|
2007-06-04 |
2008-12-17 |
GenKyo Tex |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
MY146643A
(en)
|
2007-07-30 |
2012-09-14 |
Dae Woong Pharma |
Novel benzoimidazole derivatives and pharmaceutical composition comprising the same
|
US8399448B2
(en)
|
2007-08-08 |
2013-03-19 |
Merck Serono Sa |
6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis
|
GB0716414D0
(en)
|
2007-08-22 |
2007-10-03 |
Syngenta Participations Ag |
Novel insecticides
|
WO2009032651A1
(en)
|
2007-08-31 |
2009-03-12 |
Smithkline Beecham Corporation |
Inhibitors of akt activity
|
US8314131B2
(en)
|
2007-09-21 |
2012-11-20 |
Amgen Inc. |
Triazole fused heteroaryl compounds and methods of use thereof
|
MX2010004965A
(es)
|
2007-11-01 |
2010-05-20 |
Sirtris Pharmaceuticals Inc |
Derivados de amida como moduladores de la sirtuina.
|
KR100963644B1
(ko)
|
2007-11-23 |
2010-06-15 |
한국과학기술연구원 |
피라졸로피리미딘온 유도체 및 그의 제조방법
|
EA019309B1
(ru)
|
2008-02-04 |
2014-02-28 |
Меркьюри Терапьютикс, Инк. |
Модуляторы ampk (амф-активируемой протеинкиназы)
|
US20110124634A1
(en)
|
2008-05-13 |
2011-05-26 |
Poniard Pharmaceuticals, Inc. |
Bioactive compounds for treatment of cancer and neurodegenerative diseases
|
WO2009152356A2
(en)
|
2008-06-11 |
2009-12-17 |
Irm Llc |
Compounds and compositions useful for the treatment of malaria
|
MX360970B
(es)
|
2008-06-27 |
2018-11-23 |
Avila Therapeutics Inc |
Compuestos de heteroarilo y usos de los mismos.
|
US20110294853A1
(en)
|
2008-09-12 |
2011-12-01 |
Benjamin Pelcman |
Bis Aromatic Compounds for Use in the Treatment of Inflammation
|
EP2165707A1
(en)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
EP2166008A1
(en)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
EP2166010A1
(en)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
WO2010046780A2
(en)
|
2008-10-22 |
2010-04-29 |
Institut Pasteur Korea |
Anti viral compounds
|
JP2010111624A
(ja)
|
2008-11-06 |
2010-05-20 |
Shionogi & Co Ltd |
Ttk阻害作用を有するインダゾール誘導体
|
WO2010080503A1
(en)
|
2008-12-19 |
2010-07-15 |
Genentech, Inc. |
Heterocyclic compounds and methods of use
|
KR20100101055A
(ko)
|
2009-03-07 |
2010-09-16 |
주식회사 메디젠텍 |
세포핵에서 세포질로의 gsk3의 이동을 억제하는 화합물을 함유하는 세포핵에서 세포질로의 gsk3 이동 관련 질환의 치료 또는 예방용 약학적 조성물
|
US8637507B2
(en)
|
2009-03-18 |
2014-01-28 |
Merck Sharp & Dohme Corp. |
Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
|
US9051185B2
(en)
|
2009-03-26 |
2015-06-09 |
Northeastern University |
Carbon nanostructures from pyrolysis of organic materials
|
WO2010118367A2
(en)
|
2009-04-10 |
2010-10-14 |
Progenics Pharmaceuticals, Inc. |
Antiviral pyrimidines
|
EP2464647B1
(en)
|
2009-08-11 |
2016-09-21 |
Bristol-Myers Squibb Company |
Azaindazoles as btk kinase modulators and use thereof
|
WO2011031628A1
(en)
|
2009-09-14 |
2011-03-17 |
Schering Corporation |
Inhibitors of diacylglycerol acyltransferase
|
WO2011050245A1
(en)
|
2009-10-23 |
2011-04-28 |
Yangbo Feng |
Bicyclic heteroaryls as kinase inhibitors
|
ES2360333B1
(es)
|
2009-10-29 |
2012-05-04 |
Consejo Superior De Investigaciones Cientificas (Csic) (70%) |
Derivados de bis (aralquil) amino y sistemas (hetero) aromaticos de seis miembros y su uso en el tratamiento de patologias neurodegenerativas, incluida la enfermedad de alzheimer
|
JP2013032290A
(ja)
|
2009-11-20 |
2013-02-14 |
Dainippon Sumitomo Pharma Co Ltd |
新規縮合ピリミジン誘導体
|
WO2011078143A1
(ja)
|
2009-12-22 |
2011-06-30 |
塩野義製薬株式会社 |
ピリミジン誘導体およびそれらを含有する医薬組成物
|
EP2519517B1
(en)
|
2009-12-29 |
2015-03-25 |
Dana-Farber Cancer Institute, Inc. |
Type ii raf kinase inhibitors
|
WO2011082400A2
(en)
|
2010-01-04 |
2011-07-07 |
President And Fellows Of Harvard College |
Modulators of immunoinhibitory receptor pd-1, and methods of use thereof
|
US20130109758A1
(en)
|
2010-01-06 |
2013-05-02 |
The University Of British Columbia |
Bisphenol derivative therapeutics and methods for their use
|
DE102010009903A1
(de)
|
2010-03-02 |
2011-09-08 |
Merck Patent Gmbh |
Verbindungen für elektronische Vorrichtungen
|
CN102206172B
(zh)
|
2010-03-30 |
2015-02-25 |
中国医学科学院医药生物技术研究所 |
一组取代双芳基化合物及其制备方法和抗病毒应用
|
EP2560488B1
(en)
|
2010-04-23 |
2015-10-28 |
Cytokinetics, Inc. |
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
|
ES2591004T3
(es)
|
2010-04-27 |
2016-11-24 |
Calcimedica, Inc. |
Compuestos moduladores del calcio intracelular
|
GB201008134D0
(en)
*
|
2010-05-14 |
2010-06-30 |
Medical Res Council Technology |
Compounds
|
JP2011246389A
(ja)
|
2010-05-26 |
2011-12-08 |
Oncotherapy Science Ltd |
Ttk阻害作用を有する縮環ピラゾール誘導体
|
WO2011147765A1
(de)
|
2010-05-27 |
2011-12-01 |
Bayer Cropscience Ag |
Pyridinylcarbonsäure derivate als fungizide
|
WO2011153553A2
(en)
|
2010-06-04 |
2011-12-08 |
The Regents Of The University Of California |
Methods and compositions for kinase inhibition
|
EP2582691B1
(de)
|
2010-06-15 |
2017-05-10 |
Bayer Intellectual Property GmbH |
Anthranilsäurederivate
|
WO2011158108A2
(en)
|
2010-06-16 |
2011-12-22 |
Purdue Pharma L.P. |
Aryl substituted indoles and the use thereof
|
CN103384670B
(zh)
|
2010-07-28 |
2016-05-25 |
拜耳知识产权有限责任公司 |
取代的咪唑并[1,2-b]哒嗪
|
US10005750B2
(en)
|
2010-10-06 |
2018-06-26 |
J-Pharma Co., Ltd. |
Developing potent urate transporter inhibitors: compounds designed for their uricosuric action
|
GB201017345D0
(en)
|
2010-10-14 |
2010-11-24 |
Proximagen Ltd |
Receptor antagonists
|
CA2819373A1
(en)
|
2010-12-09 |
2012-06-14 |
Amgen Inc. |
Bicyclic compounds as pim inhibitors
|
WO2012080376A1
(en)
|
2010-12-17 |
2012-06-21 |
Syngenta Participations Ag |
Insecticidal compounds
|
CA2823665A1
(en)
|
2011-01-04 |
2012-07-12 |
Novartis Ag |
Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd)
|
ES2732311T3
(es)
|
2011-02-07 |
2019-11-21 |
Univ Washington |
Compuestos de manósidos y procedimientos de uso de los mismos
|
JP6001048B2
(ja)
|
2011-03-28 |
2016-10-05 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
チアゾロピリミジン化合物
|
HUE032075T2
(en)
|
2011-04-12 |
2017-08-28 |
Chong Kun Dang Pharmaceutical Corp |
3- (2-Arylcycloalkenylmethyl) -oxazolidin-2-one derivatives as cholesterol ester transfer protein (CETP) inhibitors
|
PE20140928A1
(es)
|
2011-04-21 |
2014-08-24 |
Origenis Gmbh |
Pirazolo[4,3-d]pirimidinas utiles como inhibidores de cinasas
|
WO2012156367A1
(en)
|
2011-05-17 |
2012-11-22 |
Bayer Intellectual Property Gmbh |
Amino-substituted imidazopyridazines as mknk1 kinase inhibitors
|
WO2012158810A1
(en)
|
2011-05-17 |
2012-11-22 |
Principia Biopharma Inc. |
Tyrosine kinase inhibitors
|
UY34104A
(es)
|
2011-05-31 |
2013-01-03 |
Syngenta Participations Ag |
?compuestos derivados benzamídicos heterocíclicos, procesos e intermedios para su preparación, composiciones y métodos para su uso?.
|
CA2837630A1
(en)
|
2011-06-01 |
2012-12-06 |
Knut Eis |
Substituted aminoimidazopyridazines
|
EP2723748B1
(en)
|
2011-06-22 |
2016-10-12 |
Bayer Intellectual Property GmbH |
Heterocyclyl aminoimidazopyridazines
|
EP2543372A1
(en)
|
2011-07-08 |
2013-01-09 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Medicament for the treatment of liver cancer
|
EP3111937B1
(en)
|
2011-07-08 |
2020-06-17 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Medicament for treatment of liver cancer
|
WO2013021276A1
(en)
|
2011-08-10 |
2013-02-14 |
Purdue Pharma L.P. |
Trpv1 antagonists including dihydroxy substituent and uses thereof
|
WO2013024011A1
(en)
|
2011-08-12 |
2013-02-21 |
F. Hoffmann-La Roche Ag |
Indazole compounds, compositions and methods of use
|
EP2742046A1
(en)
|
2011-08-12 |
2014-06-18 |
F.Hoffmann-La Roche Ag |
PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE
|
WO2013042137A1
(en)
|
2011-09-19 |
2013-03-28 |
Aurigene Discovery Technologies Limited |
Bicyclic heterocycles as irak4 inhibitors
|
CA2849345A1
(en)
|
2011-09-23 |
2013-03-28 |
Bayer Intellectual Property Gmbh |
Substituted imidazopyridazines
|
CN102503959B
(zh)
|
2011-10-25 |
2015-04-08 |
南方医科大学 |
一种稠三环类化合物及其制备方法、以及含该类化合物的药物组合物及其应用
|
CN102516263B
(zh)
|
2011-10-25 |
2015-04-08 |
南方医科大学 |
一种螺三环类化合物及其制备方法、以及含该类化合物的药物组合物及其应用
|
JP6173327B2
(ja)
|
2011-11-01 |
2017-08-02 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
イミダゾピリダジン化合物
|
CN110698408B
(zh)
|
2012-02-17 |
2021-01-05 |
奇尼塔病毒性出血热有限责任公司 |
用于治疗沙粒病毒感染的抗病毒药物
|
TW201348231A
(zh)
|
2012-02-29 |
2013-12-01 |
Amgen Inc |
雜雙環化合物
|
KR20140131955A
(ko)
|
2012-03-09 |
2014-11-14 |
카나 바이오사이언스 인코포레이션 |
신규 트리아진 유도체
|
WO2013146942A1
(ja)
|
2012-03-28 |
2013-10-03 |
出光興産株式会社 |
新規化合物、有機エレクトロルミネッセンス素子用材料および有機エレクトロルミネッセンス素子
|
ES2668422T3
(es)
|
2012-04-20 |
2018-05-18 |
Gilead Sciences, Inc. |
Derivados del ácido benzotiazol-6-il acético y su uso para tratar una infección por VIH
|
WO2014003405A1
(ko)
|
2012-06-26 |
2014-01-03 |
주식회사 제이앤드제이 캐미칼 |
신규한 화합물 및 이를 포함하는 발광소자
|
KR20150035766A
(ko)
|
2012-06-28 |
2015-04-07 |
노파르티스 아게 |
피롤리딘 유도체 및 보체 경로 조절제로서의 그의 용도
|
KR101936851B1
(ko)
|
2012-07-16 |
2019-01-11 |
한국과학기술연구원 |
단백질 키나아제 저해제인 신규 피라졸로피리딘 유도체 또는 인다졸 유도체
|
WO2014024125A1
(en)
|
2012-08-08 |
2014-02-13 |
Celon Pharma S.A. |
Pyrazolo[4,3-d]pyrimidin-7(6h)-one derivatives as pde9 inhibitors
|
US20150239889A1
(en)
|
2012-08-23 |
2015-08-27 |
Mitsubishi Tanabe Pharma Corporation |
Pyrazolopyrimidine compound
|
KR102124227B1
(ko)
|
2012-09-24 |
2020-06-17 |
아리조나 보드 오브 리젠츠 온 비하프 오브 아리조나 스테이트 유니버시티 |
금속 화합물, 방법, 및 이의 용도
|
CN104837832B
(zh)
|
2012-10-05 |
2019-04-26 |
里格尔药品股份有限公司 |
Gdf-8抑制剂
|
KR102137472B1
(ko)
|
2013-02-08 |
2020-07-27 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
US9242969B2
(en)
|
2013-03-14 |
2016-01-26 |
Novartis Ag |
Biaryl amide compounds as kinase inhibitors
|
US10273243B2
(en)
|
2013-03-14 |
2019-04-30 |
The Trustees Of Columbia University In The City Of New York |
4-phenylpiperidines, their preparation and use
|
US9227978B2
(en)
|
2013-03-15 |
2016-01-05 |
Araxes Pharma Llc |
Covalent inhibitors of Kras G12C
|
US9034927B2
(en)
|
2013-05-22 |
2015-05-19 |
Curza Global, Llc |
Methods of use for compositions comprising a biocidal polyamine
|
KR102349659B1
(ko)
|
2013-06-10 |
2022-01-11 |
아리조나 보드 오브 리젠츠 온 비하프 오브 아리조나 스테이트 유니버시티 |
개질된 방출 스펙트럼을 갖는 인광성 네자리 금속 착물
|
US9718818B2
(en)
|
2013-08-22 |
2017-08-01 |
Merck Sharp & Dohme Corp. |
Compounds inhibiting leucine-rich repeat kinase enzyme activity
|
TWI652014B
(zh)
|
2013-09-13 |
2019-03-01 |
美商艾佛艾姆希公司 |
雜環取代之雙環唑殺蟲劑
|
WO2015037965A1
(en)
|
2013-09-16 |
2015-03-19 |
Rohm And Haas Electronic Materials Korea Ltd. |
Novel organic electroluminescent compounds and organic electroluminescent device comprising the same
|
WO2015058163A2
(en)
|
2013-10-18 |
2015-04-23 |
Syros Pharmaceuticals, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
WO2015061247A2
(en)
|
2013-10-21 |
2015-04-30 |
Merck Patent Gmbh |
Heteroaryl compounds as btk inhibitors and uses thereof
|
WO2015089327A1
(en)
|
2013-12-11 |
2015-06-18 |
Biogen Idec Ma Inc. |
Biaryl compounds useful for the treatment of human diseases in oncology, neurology and immunology
|
WO2015089479A1
(en)
|
2013-12-13 |
2015-06-18 |
Dana-Farber Cancer Institute, Inc. |
Methods to treat lymphoplasmacytic lymphoma
|
TWI667233B
(zh)
|
2013-12-19 |
2019-08-01 |
德商拜耳製藥公司 |
新穎吲唑羧醯胺,其製備方法、含彼等之醫藥製劑及其製造醫藥之用途
|
US9714232B2
(en)
|
2013-12-20 |
2017-07-25 |
Sunshine Lake Pharma Co., Ltd. |
Substituted piperazine compounds and methods of use thereof
|
US10160753B2
(en)
|
2014-01-10 |
2018-12-25 |
Aurigene Discovery Technologies Limited |
Indazole compounds as IRAK4 inhibitors
|
JP6640098B2
(ja)
|
2014-02-05 |
2020-02-05 |
メルク、パテント、ゲゼルシャフト、ミット、ベシュレンクテル、ハフツングMerck Patent GmbH |
金属錯体
|
BR112016019526B1
(pt)
|
2014-02-25 |
2023-03-28 |
Achillion Pharmaceuticals, Inc |
Composto, e, uso de um composto
|
US9871208B2
(en)
|
2014-02-26 |
2018-01-16 |
Samsung Display Co., Ltd. |
Condensed cyclic compound and organic light-emitting device including the same
|
WO2015164956A1
(en)
|
2014-04-29 |
2015-11-05 |
The University Of British Columbia |
Benzisothiazole derivative compounds as therapeutics and methods for their use
|
US20150328188A1
(en)
|
2014-05-19 |
2015-11-19 |
Everardus O. Orlemans |
Combination Therapies for the Treatment of Proliferative Disorders
|
KR102402729B1
(ko)
|
2014-06-18 |
2022-05-26 |
메르크 파텐트 게엠베하 |
유기 전계발광 소자용 재료
|
WO2015193506A1
(en)
|
2014-06-20 |
2015-12-23 |
Institut Pasteur Korea |
Anti-infective compounds
|
MX2016017147A
(es)
|
2014-06-20 |
2017-06-07 |
Aurigene Discovery Tech Ltd |
Compuestos de indazole substituidos como inhibidores de irak4.
|
WO2015200682A1
(en)
|
2014-06-25 |
2015-12-30 |
Vanderbilt University |
Substituted 4-alkoxypicolinamide analogs ds mglur5 negative allosteric modulators
|
KR20160007967A
(ko)
|
2014-07-10 |
2016-01-21 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
WO2016040188A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016040181A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016040180A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016040184A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016041618A1
(en)
|
2014-09-15 |
2016-03-24 |
Merck Patent Gmbh |
Substituted indazoles and related heterocycles
|
KR102523111B1
(ko)
|
2014-10-06 |
2023-04-18 |
메르크 파텐트 게엠베하 |
Btk 억제제로서 헤테로아릴 화합물 및 이들의 용도
|
JO3705B1
(ar)
|
2014-11-26 |
2021-01-31 |
Bayer Pharma AG |
إندازولات مستبدلة جديدة، عمليات لتحضيرها، مستحضرات دوائية تحتوي عليها واستخدامها في إنتاج أدوية
|
JP2017537929A
(ja)
|
2014-12-05 |
2017-12-21 |
ジェネンテック, インコーポレイテッド |
Pd−1軸アンタゴニスト及びhpk1アンタゴニストを用いたがん治療のための方法及び組成物
|
JP6772188B2
(ja)
|
2015-02-03 |
2020-10-21 |
メルク、パテント、ゲゼルシャフト、ミット、ベシュレンクテル、ハフツングMerck Patent GmbH |
金属錯体
|
WO2016144702A1
(en)
|
2015-03-06 |
2016-09-15 |
Pharmakea, Inc. |
Lysyl oxidase-like 2 inhibitors and uses thereof
|
WO2016144351A1
(en)
|
2015-03-11 |
2016-09-15 |
E. I. Du Pont De Nemours And Company |
Heterocycle-substituted bicyclic azole pesticides
|
WO2016161571A1
(en)
|
2015-04-08 |
2016-10-13 |
Merck Sharp & Dohme Corp. |
Indazole and azaindazole btk inhibitors
|
TW201701879A
(zh)
|
2015-04-30 |
2017-01-16 |
拜耳製藥公司 |
Irak4抑制劑組合
|
IL283353B
(en)
|
2015-06-25 |
2022-09-01 |
Univ Health Network |
hpk1 inhibitors and methods of using them
|
US20180208605A1
(en)
|
2015-07-15 |
2018-07-26 |
Aurigene Discovery Technologies Limited |
Substituted Aza Compounds as IRAK-4 Inhibitors
|
CU20180006A7
(es)
|
2015-07-15 |
2018-06-05 |
Aurigene Discovery Tech Ltd |
Compuestos de indazaol y azaindazol como inhibidores de irak-4
|
US10195185B2
(en)
|
2015-08-03 |
2019-02-05 |
Samumed, Llc |
3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
WO2017023894A1
(en)
|
2015-08-03 |
2017-02-09 |
Raze Therapeutics, Inc. |
Mthfd2 inhibitors and uses thereof
|
CA2995094A1
(en)
|
2015-08-07 |
2017-02-16 |
Calcimedica, Inc. |
Use of crac channel inhibitors for the treatment of stroke and traumatic brain injury
|
WO2017045955A1
(en)
|
2015-09-14 |
2017-03-23 |
Basf Se |
Heterobicyclic compounds
|
US10975071B2
(en)
|
2015-09-28 |
2021-04-13 |
Araxes Pharma Llc |
Inhibitors of KRAS G12C mutant proteins
|
WO2017108744A1
(de)
|
2015-12-22 |
2017-06-29 |
Bayer Pharma Aktiengesellschaft |
Neue substituierte indazole, verfahren zu ihrer herstellung, pharmazeutische präparate die diese enthalten, sowie deren verwendung zur herstellung von arzneimitteln
|
US10435388B2
(en)
|
2016-01-07 |
2019-10-08 |
Cs Pharmatech Limited |
Selective inhibitors of clinically important mutants of the EGFR tyrosine kinase
|
US20190262126A1
(en)
|
2016-07-19 |
2019-08-29 |
Arthur Bernard CUMMINGS |
Artificial accommodating lens complex
|
JP6740452B2
(ja)
|
2016-07-26 |
2020-08-12 |
深▲セン▼市塔吉瑞生物医▲薬▼有限公司Shenzhen TargetRx,Inc. |
プロテインチロシンキナーゼの活性を阻害するためのアミノピリミジン系化合物
|
WO2018049191A1
(en)
|
2016-09-09 |
2018-03-15 |
Incyte Corporation |
Pyrazolopyridone derivatives as hpk1 modulators and uses thereof for the treatment of cancer
|
US20180072718A1
(en)
|
2016-09-09 |
2018-03-15 |
Incyte Corporation |
Pyrazolopyridine compounds and uses thereof
|
TW201811799A
(zh)
|
2016-09-09 |
2018-04-01 |
美商英塞特公司 |
吡唑并嘧啶化合物及其用途
|
AR109596A1
(es)
|
2016-09-09 |
2018-12-26 |
Incyte Corp |
Compuestos pirazolopiridina y sus usos
|
US20180228786A1
(en)
|
2017-02-15 |
2018-08-16 |
Incyte Corporation |
Pyrazolopyridine compounds and uses thereof
|
WO2019051199A1
(en)
|
2017-09-08 |
2019-03-14 |
Incyte Corporation |
6-CYANO-INDAZOLE COMPOUNDS AS HEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) MODULATORS
|
US10745388B2
(en)
|
2018-02-20 |
2020-08-18 |
Incyte Corporation |
Indazole compounds and uses thereof
|
UA128286C2
(uk)
|
2018-02-20 |
2024-05-29 |
Інсайт Корпорейшн |
Похідні n-(феніл)-2-(феніл)піримідин-4-карбоксаміду та родинні сполуки як інгібітори hpk1 для лікування раку
|
US10752635B2
(en)
|
2018-02-20 |
2020-08-25 |
Incyte Corporation |
Indazole compounds and uses thereof
|
US11299473B2
(en)
|
2018-04-13 |
2022-04-12 |
Incyte Corporation |
Benzimidazole and indole compounds and uses thereof
|
PE20201202A1
(es)
|
2018-04-26 |
2020-11-11 |
Pfizer |
Inhibidores de cinasa dependientes de ciclina
|
MA52483A
(fr)
|
2018-05-04 |
2021-03-10 |
Novo Nordisk As |
Dérivés de gip et leurs utilisations
|
EP3793559A1
(en)
|
2018-05-17 |
2021-03-24 |
Bayer Aktiengesellschaft |
Substituted dihydropyrazolo pyrazine carboxamide derivatives
|
US10899755B2
(en)
|
2018-08-08 |
2021-01-26 |
Incyte Corporation |
Benzothiazole compounds and uses thereof
|
CR20220097A
(es)
|
2019-08-06 |
2022-06-01 |
Incyte Corp |
Formas sólidas de un inhibidor de hpk1
|